BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15084349)

  • 1. Flavonoid inhibition of overexpressed human 3beta-hydroxysteroid dehydrogenase type II.
    Ohno S; Matsumoto N; Watanabe M; Nakajin S
    J Steroid Biochem Mol Biol; 2004 Feb; 88(2):175-82. PubMed ID: 15084349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of flavonoid phytochemicals on cortisol production and on activities of steroidogenic enzymes in human adrenocortical H295R cells.
    Ohno S; Shinoda S; Toyoshima S; Nakazawa H; Makino T; Nakajin S
    J Steroid Biochem Mol Biol; 2002 Mar; 80(3):355-63. PubMed ID: 11948020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary estrogenic isoflavones are potent inhibitors of beta-hydroxysteroid dehydrogenase of P. testosteronii.
    Keung WM
    Biochem Biophys Res Commun; 1995 Oct; 215(3):1137-44. PubMed ID: 7488041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human and rat 3beta-hydroxysteroid dehydrogenase and 17beta-hydroxysteroid dehydrogenase 3 activities by perfluoroalkylated substances.
    Zhao B; Hu GX; Chu Y; Jin X; Gong S; Akingbemi BT; Zhang Z; Zirkin BR; Ge RS
    Chem Biol Interact; 2010 Oct; 188(1):38-43. PubMed ID: 20619251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of 3alpha-hydroxysteroid dehydrogenase (3alpha-HSD) activity of human lung microsomes by genistein, daidzein, coumestrol and C(18)-, C(19)- and C(21)-hydroxysteroids and ketosteroids.
    Blomquist CH; Lima PH; Hotchkiss JR
    Steroids; 2005 Jul; 70(8):507-14. PubMed ID: 15894034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells.
    Sanderson JT; Hordijk J; Denison MS; Springsteel MF; Nantz MH; van den Berg M
    Toxicol Sci; 2004 Nov; 82(1):70-9. PubMed ID: 15319488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human-type 1 3beta-hydroxysteroid deshydrogenase/Delta(5)-Delta(4)-isomerase expression using siRNA.
    Samson M; Labrie F; Luu-The V
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):253-7. PubMed ID: 15862972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro exposure of porcine granulosa cells to the phytoestrogens genistein and daidzein: effects on the biosynthesis of reproductive steroid hormones.
    Tiemann U; Schneider F; Vanselow J; Tomek W
    Reprod Toxicol; 2007; 24(3-4):317-25. PubMed ID: 17728101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trihydroxynaphthalene reductase of Curvularia lunata--a target for flavonoid action?
    Brunskole M; Zorko K; Kerbler V; Martens S; Stojan J; Gobec S; Lanisnik Rizner T
    Chem Biol Interact; 2009 Mar; 178(1-3):259-67. PubMed ID: 19010313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troglitazone is a competitive inhibitor of 3beta-hydroxysteroid dehydrogenase enzyme in the ovary.
    Gasic S; Nagamani M; Green A; Urban RJ
    Am J Obstet Gynecol; 2001 Mar; 184(4):575-9. PubMed ID: 11262455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine adrenal 3beta-hydroxysteroid dehydrogenase (E.C. 1.1.1. 145)/5-ene-4-ene isomerase (E.C. 5.3.3.1): characterization and its inhibition by isoflavones.
    Wong CK; Keung WM
    J Steroid Biochem Mol Biol; 1999 Dec; 71(5-6):191-202. PubMed ID: 10704908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androsterone 3alpha-ether-3beta-substituted and androsterone 3beta-substituted derivatives as inhibitors of type 3 17beta-hydroxysteroid dehydrogenase: chemical synthesis and structure-activity relationship.
    Tchédam Ngatcha B; Luu-The V; Labrie F; Poirier D
    J Med Chem; 2005 Aug; 48(16):5257-68. PubMed ID: 16078844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital adrenal hyperplasia due to 3beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase deficiency.
    Simard J; Moisan AM; Morel Y
    Semin Reprod Med; 2002 Aug; 20(3):255-76. PubMed ID: 12428206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3Beta-alkyl-androsterones as inhibitors of type 3 17beta-hydroxysteroid dehydrogenase: inhibitory potency in intact cells, selectivity towards isoforms 1, 2, 5 and 7, binding affinity for steroid receptors, and proliferative/antiproliferative activities on AR+ and ER+ cell lines.
    Ngatcha BT; Laplante Y; Labrie F; Luu-The V; Poirier D
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):225-32. PubMed ID: 16359782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine 124 completes the Tyr, Lys and Ser triad responsible for the catalysis of human type 1 3beta-hydroxysteroid dehydrogenase.
    Thomas JL; Duax WL; Addlagatta A; Scaccia LA; Frizzell KA; Carloni SB
    J Mol Endocrinol; 2004 Aug; 33(1):253-61. PubMed ID: 15291757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids.
    Skarydová L; Zivná L; Xiong G; Maser E; Wsól V
    Chem Biol Interact; 2009 Mar; 178(1-3):138-44. PubMed ID: 19007764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of type 2 17beta-hydroxysteroid dehydrogenase by estradiol derivatives bearing a lactone on the D-ring: structure-activity relationships.
    Bydal P; Auger S; Poirier D
    Steroids; 2004 May; 69(5):325-42. PubMed ID: 15219411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
    Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
    Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of human and rat testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD) as potential agents for prostatic cancer.
    Le Lain R; Nicholls PJ; Smith HJ; Maharlouie FH
    J Enzyme Inhib; 2001 Jan; 16(1):35-45. PubMed ID: 11496833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship of human GLO I inhibitory natural flavonoids and their growth inhibitory effects.
    Takasawa R; Takahashi S; Saeki K; Sunaga S; Yoshimori A; Tanuma S
    Bioorg Med Chem; 2008 Apr; 16(7):3969-75. PubMed ID: 18258440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.